EpiScalp is a new tool designed to improve the accuracy of EEG recordings and reduce epilepsy misdiagnoses by as much as 70%, ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Further studies are needed to evaluate the long-term toxicity effects of rapamycin as a candidate for a novel epilepsy drug. In addition, it is necessary to conduct similar studies using other models ...

who are going to extreme lengths to obtain these medicinal cannabis oils to treat their severely epileptic children. As well as sourcing the drugs illegally online, some are regularly smuggling it ...

The Medicare drug list, also called a formulary, lists the prescription drugs and vaccines that Medicare covers. Medicare provides this coverage through Medicare Part D or Medicare Advantage (also ...

Before the advent of medications, individuals with these more extreme symptoms often found themselves stuck—unable to engage meaningfully in therapy or, in many cases, requiring long-term ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

GW Pharmaceuticals’ cannabis-derived drug Epidyolex has been approved in Europe for two kinds of rare childhood epilepsy. The European Commission approved the drug, an oral solution containing ...

Analyses of large databases have provided clarity on the lived experiences of people with epilepsy regarding the initiation of or changes to their antiseizure medications. The past year has also seen ...

It's important not to overuse headache medications, as it can lead to new or worse symptoms. Your doctor can help you understand different headache treatments and how to use them safely.

The Los Angeles fires have forced thousands to evacuate indefinitely from their homes, often without necessary medications or medical devices. Here’s what to do if you find yourself without ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...